Gerald E. Hanks

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference

Mack Roach, Gerald E. Hanks, Howard D. Thames et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 2.7K citations

Medicine, Radiation Oncology, Urology +14

Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02

Gerald E. Hanks, Thomas F. Pajak, Arthur T. Porter et al. · Journal of Clinical Oncology · 2003 · 694 citations

Medicine, Oncology, Radiation Oncology +17

Ten-Year Follow-Up of Radiation Therapy Oncology Group Protocol 92-02: A Phase III Trial of the Duration of Elective Androgen Deprivation in Locally Advanced Prostate Cancer

Eric M. Horwitz, Kyounghwa Bae, Gerald E. Hanks et al. · Journal of Clinical Oncology · 2008 · 691 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31.

Miljenko V. Pilepich, Richard Caplan, Roger W. Byhardt et al. · Journal of Clinical Oncology · 1997 · 609 citations

Medicine, Oncology, Urology +17

Radiation Therapy for Clinically Localized Prostate Cancer

William U. Shipley, Howard D. Thames, Howard M. Sandler et al. · JAMA · 1999 · 447 citations

Medicine, Oncology, Urology +17